
Published On: Sep 2020
Published On: Sep 2020
Artificial tears Segment Held Largest Share of Europe Dry Eye Product Market in 2019
According to a new market research study of ‘Europe Dry eye Product Market to 2027 – Regional Analysis and Forecast by Product, and Type,’ the Europe dry eye product market is expected to reach US$ 2631.70 million by 2027 from US$ 1868.93million in 2019. The market is estimated to grow with a CAGR of 4.6% from 2020 to 2027. The report provides trends prevailing in the Europe dry eye product market and the factors driving market along with those that act as hindrances.
Based on the product , the Europe dry eye product market is segmented into artificial drops, antibiotic drops, hormone drops, others. The artificial tears segment held the largest share of the market in 2019, whereas Hormone drops possess highest CAGR in the market during the forecast period. The growth of artificial tears segment the is attributed to accuracy and the minimum side effects, preference by the pharmacies and hospitals for the artificial tears, enormous commercial use of these products in the market and as well as the changing lifestyle related factors.
The Europe Dry eye Product market is expected to grow owing to the increasing incidences as well as the chances of dry eye and rising geriatric population across the globe. However, major occurrence of the side effects is expected to restraint the growth of the market during the forecast period.
Novartis AG, Santen Pharmaceuticals co. Ltd, Johnson and Johnson are among the leading companies operating in the Europe Dry eye Product market.
The report segments Europe Dry eye Product Market as Follows:
Europe Dry eye Product Market – By Product
Europe Dry eye Product Market – By Type
Europe Dry eye Product Market– By Country